Clinical Trial Update: Optimizing the Dose of Flucytosine for the Treatment of Cryptococcal Meningitis [Phase 2]

View source ↗

Summary

Phase 2 trial results report on optimizing the dosing of flucytosine for cryptococcal meningitis, with results posted after completion. The study evaluated dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryptococcal Meningitis

Drugs mentioned

• Flucytosine (flucytosine)

Snippet

Sponsor: University of Minnesota | Conditions: Cryptococcal Meningitis | Phase 2 | Status: COMPLETED | Results posted: 2025-08-27